Nkarta Inc (NKTX)

Apr 02, 2025

Charles Schwab Investment Management Inc. Cuts Stock Holdings in Nkarta, Inc. (NASDAQ:NKTX) - Defense World

Apr 02, 2025

Apr 01, 2025

Nkarta to Participate in an April Investor Conference - GlobeNewswire

Apr 01, 2025

Apr 01, 2025

NK Cell Pioneer Nkarta Takes Center Stage at Major Healthcare Conference - Stock Titan

Apr 01, 2025

Apr 01, 2025

Leerink Partnrs Has Bullish Outlook for Nkarta Q1 Earnings - The AM Reporter

Apr 01, 2025

Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025

Mar 31, 2025

Nkarta: Grinding Lower, Trying To Find Support (NASDAQ:NKTX) - Seeking Alpha

Mar 31, 2025

Mar 31, 2025

Nkarta: Betting On The Turnaround (NASDAQ:NKTX) - Seeking Alpha

Mar 31, 2025

Mar 31, 2025

Leerink Partnrs Has Strong Forecast for Nkarta Q1 Earnings - Defense World

Mar 31, 2025

Mar 31, 2025

What is HC Wainwright’s Forecast for Nkarta Q1 Earnings? - Defense World

Mar 31, 2025

Mar 30, 2025

Nkarta, Inc. (NASDAQ:NKTX) Receives $14.86 Average Price Target from Brokerages - Defense World

Mar 30, 2025

Mar 29, 2025

Stifel Nicolaus Has Lowered Expectations for Nkarta (NASDAQ:NKTX) Stock Price - Defense World

Mar 29, 2025

Mar 29, 2025

HC Wainwright Reiterates Buy Rating for Nkarta (NASDAQ:NKTX) - Defense World

Mar 29, 2025

Mar 27, 2025

Nkarta’s Strategic Workforce Reduction and Clinical Progress Justify Buy Rating - TipRanks

Mar 27, 2025

Mar 27, 2025

Analysts Adjust Price Targets For Nkarta And Bicara - Evrim Ağacı

Mar 27, 2025

Mar 27, 2025

Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday? - Benzinga

Mar 27, 2025

Mar 27, 2025

Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy - BioPharma Dive

Mar 27, 2025

Mar 27, 2025

Stifel cuts Nkarta stock price target to $14, maintains buy rating - Investing.com India

Mar 27, 2025

Mar 27, 2025

Nkarta to lay off 34% of staff; Savara’s debt financing deal - Endpoints News

Mar 27, 2025

Mar 27, 2025

H.C. Wainwright maintains Buy on Nkarta stock with $18 target - Investing.com

Mar 27, 2025

Mar 27, 2025

Nkarta lays off 3rd of staff to fund autoimmune CAR NK program - Fierce Biotech

Mar 27, 2025

Mar 27, 2025

Newly pivoted to autoimmune, Nkarta trims staff by over third - FirstWord Pharma

Mar 27, 2025

Mar 27, 2025

Nkarta’s Strategic Restructuring and NKX019 Progress Drive Buy Rating - TipRanks

Mar 27, 2025

Mar 26, 2025

Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - GlobeNewswire

Mar 26, 2025

Mar 26, 2025

Nkarta Posts Narrower Q4 Loss; Discloses Restructuring Plan - Marketscreener.com

Mar 26, 2025

Mar 26, 2025

Nkarta Announces Major Restructuring and Leadership Changes - TipRanks

Mar 26, 2025

Mar 26, 2025

Nkarta Inc To Reduce Workforce By 34%, Impacting 53 PositionsSEC Filing - MarketScreener

Mar 26, 2025

Mar 26, 2025

Nkarta Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025

Mar 26, 2025

Nkarta's Strategic Reset: 34% Staff Cut Powers 5-Year Cash Runway with $380M War Chest - Stock Titan

Mar 26, 2025

Mar 21, 2025

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month - MSN

Mar 21, 2025

Mar 20, 2025

Nkarta (NKTX) Loses -33.62% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Mar 20, 2025

Mar 19, 2025

Nkarta (NKTX) Loses -32.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Mar 19, 2025

Mar 17, 2025

Nkarta Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView

Mar 17, 2025

Mar 13, 2025

Nkarta (NKTX) Projected to Post Earnings on Thursday - Defense World

Mar 13, 2025

Mar 03, 2025

NKTX stock touches 52-week low at $1.69 amid market challenges - Investing.com

Mar 03, 2025

Mar 01, 2025

Comparing Tempest Therapeutics (NASDAQ:TPST) & Nkarta (NASDAQ:NKTX) - Defense World

Mar 01, 2025

Feb 27, 2025

Will Nkarta (NASDAQ:NKTX) Spend Its Cash Wisely? - Simply Wall St

Feb 27, 2025

Feb 25, 2025

Nkarta to Participate in March Investor Conferences - The Manila Times

Feb 25, 2025

Feb 24, 2025

NKTX stock touches 52-week low at $1.96 amid market challenges - Investing.com

Feb 24, 2025

Feb 18, 2025

Leerink Partnrs Forecasts Nkarta FY2029 Earnings - MarketBeat

Feb 18, 2025

Feb 17, 2025

Leerink Partnrs Comments on Nkarta FY2024 Earnings - Defense World

Feb 17, 2025

Feb 16, 2025

Leerink Partnrs Comments on Nkarta FY2029 Earnings - Defense World

Feb 16, 2025

Feb 15, 2025

Nkarta, Inc. (NASDAQ:NKTX) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Feb 15, 2025

Feb 11, 2025

Stock Performance Spotlight: Nkarta Inc (NKTX) Ends the Day at 2.09, Down by -3.69 - The Dwinnex

Feb 11, 2025

Feb 11, 2025

Nkarta, Inc. (NASDAQ:NKTX) Given Consensus Rating of “Buy” by Brokerages - Defense World

Feb 11, 2025

Feb 06, 2025

A new trading data show Nkarta Inc (NKTX) is showing positive returns. - SETE News

Feb 06, 2025

Feb 06, 2025

Vasculitis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | R-Pharm Overseas, Abbvie, Toleranzia, Ambulero, Visterra, CytoDyn - The Globe and Mail

Feb 06, 2025

Feb 05, 2025

Monitoring Nkarta Inc (NKTX) after recent insider movements - Knox Daily

Feb 05, 2025

Feb 04, 2025

The Potential Rise in the Price of Trane Technologies plc (TT) following insiders activity - Knox Daily

Feb 04, 2025

Feb 04, 2025

Closing Figures: Nkarta Inc (NKTX)’s Negative Finish at 2.17, Down -7.26 - The Dwinnex

Feb 04, 2025

Jan 28, 2025

TANG CAPITAL MANAGEMENT LLC Increases Stake in Nkarta Inc - GuruFocus

Jan 28, 2025

Jan 27, 2025

What Does Nkarta Inc’s (NASDAQ: NKTX) Future Hold? - Stocks Register

Jan 27, 2025